Gianenrico Senna to Italy
This is a "connection" page, showing publications Gianenrico Senna has written about Italy.
Connection Strength
0.084
-
Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real life. Immunotherapy. 2019 06; 11(9):783-794.
Score: 0.034
-
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021 01; 176:106261.
Score: 0.010
-
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life. Pulm Pharmacol Ther. 2019 02; 54:87-89.
Score: 0.008
-
The Severe Asthma Network in Italy: Findings and Perspectives. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1462-1468.
Score: 0.008
-
Thunderstorm Asthma: A Critical Appraisal Based on Clinical Practice. J Investig Allergol Clin Immunol. 2018 Aug; 28(4):273-275.
Score: 0.008
-
Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population. J Asthma. 2019 01; 56(1):27-33.
Score: 0.008
-
Evaluation of asthma control in the pharmacy: an Italian cross-sectional study. Eur Ann Allergy Clin Immunol. 2017 Sep; 49(5):225-230.
Score: 0.008